Veeva Systems Inc income statement
In fiscal 2026, Veeva Systems Inc reported revenue of $3.20bn, up 16.3% on the year before, operating income of $916m (a 28.7% margin) and net income of $909m, or $5.44 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2012Jan 2012 | 2013Jan 2013 | 2014Jan 2014 | 2015Jan 2015 | 2016Jan 2016 | 2017Jan 2017 | 2018Jan 2018 | 2019Jan 2019 | 2020Jan 2020 | 2021Jan 2021 | 2022Jan 2022 | 2023Jan 2023 | 2024Jan 2024 | 2025Jan 2025 | 2026Jan 2026 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 61 | 130 | 210 | 313 | 409 | 551 | 691 | 862 | 1,104 | 1,465 | 1,851 | 2,155 | 2,364 | 2,747 | 3,195 | 3,458 |
| Cost of revenue | 29 | 57 | 83 | 116 | 142 | 174 | 211 | 245 | 303 | 409 | 504 | 609 | 677 | 700 | 782 | 866 |
| Gross profit | 32 | 73 | 128 | 198 | 267 | 377 | 479 | 617 | 801 | 1,056 | 1,347 | 1,546 | 1,686 | 2,047 | 2,413 | 2,592 |
| Research and development | 8 | 15 | 26 | 41 | 66 | 97 | 132 | 159 | 210 | 294 | 382 | 520 | 629 | 693 | 767 | 822 |
| Selling and marketing | 12 | 19 | 42 | 56 | 81 | 111 | 129 | 149 | 190 | 235 | 288 | 349 | 381 | 397 | 429 | 459 |
| General and administrative | 6 | 8 | 20 | 30 | 41 | 49 | 60 | 86 | 114 | 149 | 172 | 218 | 247 | 266 | 301 | 277 |
| Operating income | 7 | 30 | 39 | 70 | 79 | 121 | 158 | 223 | 286 | 378 | 505 | 459 | 429 | 691 | 916 | 1,035 |
| Income before tax | 7 | 29 | 39 | 67 | 79 | 122 | 166 | 239 | 314 | 394 | 512 | 509 | 588 | 919 | 1,195 | 1,327 |
| Income tax | 2 | 10 | 15 | 27 | 24 | 45 | 15 | 9 | 13 | 14 | 85 | 21 | 62 | 205 | 286 | 313 |
| Net income | 4 | 19 | 24 | 40 | 54 | 78 | 151 | 230 | 301 | 380 | 427 | 488 | 526 | 714 | 909 | 1,015 |
| Diluted EPS | $0.01 | $0.06 | $0.07 | $0.28 | $0.38 | $0.53 | $0.98 | $1.47 | $1.90 | $2.36 | $2.63 | $3.00 | $3.22 | $4.32 | $5.44 | $6.10 |
| Diluted shares (average) | 50m | 61m | 136m | 144m | 145m | 148m | 154m | 156m | 158m | 161m | 162m | 162m | 163m | 165m | 167m | 166m |
| EBITDA | 7 | 31 | 42 | 74 | 87 | 135 | 172 | 237 | 306 | 387 | 512 | 465 | 435 | — | — | — |
| Quarter | 2025 Q3Oct 2024 | 2025 Q4Jan 2025 | 2026 Q1Apr 2025 | 2026 Q2Jul 2025 | 2026 Q3Oct 2025 | 2026 Q4Jan 2026 | 2027 Q1Apr 2026 | 2027 Q2Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 699 | 721 | 759 | 789 | 811 | 836 | 883 | 928 |
| Cost of revenue | 174 | 181 | 174 | 195 | 199 | 213 | 221 | 232 |
| Gross profit | 525 | 540 | 585 | 594 | 612 | 622 | 662 | 696 |
| Research and development | 172 | 182 | 184 | 193 | 192 | 199 | 208 | 223 |
| Selling and marketing | 99 | 99 | 99 | 109 | 111 | 110 | 111 | 127 |
| General and administrative | 72 | 71 | 69 | 96 | 68 | 68 | 69 | 71 |
| Operating income | 181 | 188 | 234 | 196 | 241 | 246 | 273 | 275 |
| Income before tax | 242 | 245 | 299 | 265 | 313 | 318 | 348 | 350 |
| Income tax | 56 | 50 | 71 | 65 | 77 | 73 | 87 | 76 |
| Net income | 186 | 196 | 228 | 200 | 236 | 244 | 261 | 273 |
| Diluted EPS | $1.13 | $1.17 | $1.37 | $1.19 | $1.40 | $1.48 | $1.57 | $1.66 |
Compare with peers
- Teladoc Health, Inc. income statement
- Tempus AI, Inc. income statement
- Solventum income statement
- Waystar Holding Corp. income statement
- Omnicell, Inc. income statement
Head to head: TDOC vs VEEVTEM vs VEEVSOLV vs VEEV
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies